Semanteon Capital Management LP Purchases Shares of 2,427 Axon Enterprise, Inc. (NASDAQ:AXON)

Semanteon Capital Management LP purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,427 shares of the biotechnology company's stock, valued at approximately $1,442,000.

A number of other institutional investors and hedge funds also recently modified their holdings of AXON. Asset Dedication LLC grew its position in Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock worth $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after buying an additional 20 shares in the last quarter. Venturi Wealth Management LLC raised its position in Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after buying an additional 21 shares during the period. Insigneo Advisory Services LLC lifted its stake in Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after acquiring an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC boosted its position in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after acquiring an additional 24 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Remove Ads

Axon Enterprise Stock Performance

Shares of AXON stock traded up $4.66 during trading on Tuesday, reaching $577.18. The company had a trading volume of 439,520 shares, compared to its average volume of 835,219. The company has a market capitalization of $44.23 billion, a PE ratio of 149.14, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm's 50 day simple moving average is $591.98 and its two-hundred day simple moving average is $545.11. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. TD Cowen started coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, Barclays reissued a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $604.67.

Insider Buying and Selling

In other news, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.